Medicine guide

Lisdexamfetamine Dimesylate

20 mg · Capsule

  • Prescription only
  • Controlled substance · CII
  • Central Nervous System Stimulant
Made by
Lannett Company, Inc.

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Medicine groupPain, sleep, mood, epilepsy and the brain

This information is not included in the verified source. Open the official leaflet

How it works

From the US prescribing label for the same active substance (LISDEXAMFETAMINE DIMESYLATE). It describes the substance, not this exact product.

Lisdexamfetamine is a prodrug of dextroamphetamine.

Amphetamines are non-catecholamine sympathomimetic amines with CNS stimulant activity.

How the body breaks it down

Lisdexamfetamine is not metabolized by cytochrome P450 enzymes.

With food

Effect of food on capsule formulation Neither food (a high fat meal or yogurt) nor orange juice affects the observed AUC and C max of dextroamphetamine in healthy adults after single-dose oral administration of 70 mg of lisdexamfetamine dimesylate capsules.

Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-07-07

Safety of the active substance

From the US prescribing label for the same active substance (LISDEXAMFETAMINE DIMESYLATE). It describes the substance, not this exact product.

Serious warning

WARNING: ABUSE, MISUSE, AND ADDICTION Lisdexamfetamine dimesylate has a high potential for abuse and misuse, which can lead to the development of a substance use disorder, including addiction.

Must not be used by
  • Lisdexamfetamine dimesylate is contraindicated in patients with: Known hypersensitivity to amphetamine products or other ingredients of lisdexamfetamine dimesylate capsules and lisdexamfetamine dimesylate chewable tablets.
  • Anaphylactic reactions, Stevens-Johnson Syndrome, angioedema, and urticaria have been observed in postmarketing reports [see Adverse Reactions ( 6.2 )].
  • Patients taking monoamine oxidase inhibitors (MAOIs), or within 14 days of stopping MAOIs (including MAOIs such as linezolid or intravenous methylene blue), because of an increased risk of hypertensive crisis [see Warnings and Precautions ( 5.7 ) and Drug Interactions ( 7.1 )].
  • Known hypersensitivity to amphetamine products or other ingredients in lisdexamfetamine dimesylate capsules and lisdexamfetamine dimesylate chewable tablets ( 4 ) Use with monoamine oxidase (MAO) inhibitor, or within 14 days of the last MAO inhibitor dose ( 4, 7.1 )
Most common side effects

The most frequently reported adverse reactions (1% or more and twice rate of placebo) were ECG voltage criteria for ventricular hypertrophy, tic, vomiting, psychomotor hyperactivity, insomnia, decreased appetite and rash [2 instances for each adverse reaction, i.e., 2/218 (1%)].

Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

Details

Made byLannett Company, Inc.
Active substanceLisdexamfetamine Dimesylate
Used inPain, sleep, mood, epilepsy and the brain
Strength20 mg
FormCapsule
RouteOral
Packs100 CAPSULE in 1 BOTTLE
NDC0527-4662

Source: NDC Directory · 2026-09-13 · not reviewed by a clinician

Source: US Food and Drug Administration, NDC Directory. Reuse terms: US government work (FDA).

Other strengths and forms

159 products are sold under this name. Grouped by form; a number on a strength means several companies make it.

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.